ARCHIVES

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Approves Tamoxifen For DCIS Folowing Breast Surgery And Radiation.

July 28, 2000

FIT More Effective Than gFOBT In All Colonoscopy Capacities

November 25, 2011

In Brief: Hutchinson Begins Prostate Cancer Study; Meyer Named GWU Medical Dean; Nurses Win VA Posts

April 9, 1993

Robert Day Named New Director At Hutchinson Center

June 19, 1981

Patient Advocacy: Breast Cancer Coalition Forms PAC To Increase Political Activities

April 18, 1997

FDA Approves New Indication For Anticoagulant Frangmin

May 25, 2007